Sort
27,075 grants matching “cholesterol”
HDL metabolism: Influence of extracellular lipases
$393,750Daniel James Rader · University Of Pennsylvania · R37 · FY2009 · HL
Molecular tools for cholesterol metabolite signaling
$393,720Alison Evelynn Ondrus · University Of Illinois At Chicago · R35 · FY2025 · GM
Characterization of mammalian COG complex-interacting Golgi trafficking machinery
$393,717Vladimir V Lupashin · Univ Of Arkansas For Med Scis · R01 · FY2018 · GM
Assembly and Secretion of APOB Containing Lipoproteins
$393,699Henry N Ginsberg · Columbia University Health Sciences · R01 · FY2013 · HL
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$393,599Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$393,577Mandana Khalili · University Of California, San Francisco · U01 · FY2024 · DK
Cholesterol Toxicity as a Promising Target for Diabetes Prevention
$393,543Jeffrey S Elmendorf · Indiana University Indianapolis · R01 · FY2019 · DK
Role of Sterols and Insulin in Cardiac Autonomic Response
$393,525Jonas Bernard Galper · Tufts Medical Center · R01 · FY2012 · HL
Role of Pannexins in Vascular Smooth Muscle Cells
$393,523Brant E Isakson · University Of Virginia · P01 · FY2018 · HL
Role of Pannexins in Vascular Smooth Muscle Cells
$393,523Brant E Isakson · University Of Virginia · P01 · FY2016 · HL
Role of Pannexins in Vascular Smooth Muscle Cells
$393,523Brant E Isakson · University Of Virginia · P01 · FY2017 · HL
Role of Pannexins in Vascular Smooth Muscle Cells
$393,523Brant E Isakson · University Of Virginia · P01 · FY2014 · HL
Genetic insights into atherosclerosis and other cardiovascular diseases
$393,522Paul M Hwang · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Collaborative Cross of the Microbiome and Metabolic Disease
$393,488Federico E Rey · University Of Wisconsin-Madison · R01 · FY2019 · DK
Novel approaches to obesity: modulation of intestinal glucose absorption in humans
$393,471Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Role of microRNA-33 in Alzheimer's disease
$393,461Jungsu Kim · Mayo Clinic Jacksonville · R01 · FY2017 · AG
Methods to Improve Personalized Cardiovascular Disease Prevention Across the Life Course
$393,437Lihui Zhao · Northwestern University At Chicago · R01 · FY2017 · HL
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$393,424Mandana Khalili · University Of California, San Francisco · U01 · FY2025 · DK
Arterial stiffening and SMC mechanobiology in Hutchinson-Guilford Progeria Syndrome
$393,374Richard Assoian · University Of Pennsylvania · R01 · FY2020 · AG
Intracerebroventricular cyclodextrin and AAV-mediated gene therapy forglobal CNS disease correction in feline NPC1 disease
$393,355Charles H Vite · University Of Florida · R01 · FY2024 · NS
Modeling the Developmental Origins of Adult Disease Risk Factors
$393,332Linda S Adair · Univ Of North Carolina Chapel Hill · R01 · FY2012 · HD
Regulation of Cellular Cholesterol Homeostasis
$393,244Peter John Espenshade · Johns Hopkins University · R01 · FY2015 · HL
Regulation of Cellular Cholesterol Homeostasis
$393,185Peter John Espenshade · Johns Hopkins University · R01 · FY2013 · HL
Relapse Prevention: Long-Acting Atypical Antipsychotics
$393,181Peter F Buckley · Augusta University · U01 · FY2009 · MH
Roles for microRNA-122 in hepatitis C virus RNA amplification
$393,160Peter Sarnow · Stanford University · R01 · FY2015 · AI